Qube Research & Technologies (QRT)
SGMO

Qube Research & Technologies (QRT)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-165,367
Closed -$169K – 3835
2024
Q4 		$169K Buy
+165,367
New +$302K ﹤0.01% 2874
2024
Q3 		– Sell
-199,788
Closed -$71.6K – 4016
2024
Q2 		$71.6K Buy
+199,788
New +$108K ﹤0.01% 2665
2024
Q1 		– Sell
-4,533
Closed -$2.46K – 4833
2023
Q4 		$2.46K Sell
4,533
-1,172
-21% -$540 ﹤0.01% 3803
2023
Q3 		$3.42K Sell
5,705
-284,009
-98% -$304K ﹤0.01% 3508
2023
Q2 		$377K Sell
289,714
-551,546
-66% -$754K ﹤0.01% 1596
2023
Q1 		$1.48M Buy
841,260
+620,577
+281% +$1.77M 0.01% 1136
2022
Q4 		$693K Buy
220,683
+135,890
+160% +$527K ﹤0.01% 1359
2022
Q3 		$415K Buy
84,793
+9,373
+12% +$48.1K ﹤0.01% 1532
2022
Q2 		$312K Buy
75,420
+6,986
+10% +$30.2K ﹤0.01% 1579
2022
Q1 		$398K Buy
+68,434
New +$407K ﹤0.01% 1642
2021
Q4 		– Sell
-22,012
Closed -$198K – 2920
2021
Q3 		$198K Buy
+22,012
New +$218K ﹤0.01% 1662
2021
Q1 		– Sell
-24,452
Closed -$382K – 2359
2020
Q4 		$382K Sell
24,452
-3,577
-13% -$41.9K 0.01% 1254
2020
Q3 		$265K Sell
28,029
-17,977
-39% -$194K ﹤0.01% 1291
2020
Q2 		$412K Buy
+46,006
New +$427K 0.01% 1192

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SGMO Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 165,367 shares — an estimated $169K sold.

Qube Research & Technologies (QRT) first reported a position in SGMO in Q2 2020 and held it in 14 quarters. The position peaked at $1.48M in Q1 2023. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 165,367 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $169K.
  • Qube Research & Technologies (QRT) first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and held it in 14 quarters.
  • Qube Research & Technologies (QRT)'s SANGAMO THERAPEUTICS INC position peaked at $1.48M in Q1 2023.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.